New scientific study about Andropenis® Penile extender is published “Applying Extender devices in Patients with Penile Dysmorphophobia” Dr. Nowroozi conducted this study to assess the efficacy and safety of Andropenis (Andromedical) penile extender. Published in The Journal of Sexual Medicine.
Most men seeking penile enhancement techniques have a normal penile size. They are either misinformed or suffer from penile dysmorphophobia and should be discouraged from undergoing invasive procedures. Less invasive techniques including penile extenders are not associated with major complications and may be beneficial from a psychological perspective.
Dr. Nowroozi conducted this study to assess the efficacy and safety of AndroPenis® (Andromedical, Madrid, Spain) penile extender.
At 6-month follow-up, a mean gain of 1.7 ± 0.8, 1.3 ± 0.4, and 1.2 ± 0.4 cm was noted for the flaccid, stretched, and erected penile lengths, respectively (all P values < 0.001). During the off treatment period, there were no significant changes in penile lengths. No effect on penile girth was observed. Patient satisfaction survey revealed modest satisfaction. From 13 patients with mild baseline erectile dysfunction, nine patients reported normal erectile function after 9 months.
Penile extender as a minimally invasive technique is safe and provides modest benefits and patient satisfaction. Nowroozi MR, Amini E, Ayati M, Jamshidian H, Radkhah K, and Amini S. Applying extender devices in patients with penile dysmorphophobia: Assessment of tolerability, efficacy, and impact on erectile function. J Sex Med 2015;12:1242–1247.
More info: http://onlinelibrary.wiley.com/doi/10.1111/jsm.12870/abstract
€99 / $99
85 £ / 149 AU$-CA$